We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$804M
AUM Growth
+$62.4M
Cap. Flow
+$3.16M
Cap. Flow %
0.39%
Top 10 Hldgs %
27.6%
Holding
264
New
30
Increased
63
Reduced
144
Closed
15

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.84M
2
DELL icon
Dell
DELL
+$4.44M
3
MU icon
Micron Technology
MU
+$3.99M
4
IBM icon
IBM
IBM
+$2.52M
5
MDT icon
Medtronic
MDT
+$2.35M

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Financials 11.52%
3 Healthcare 8.37%
4 Communication Services 6.65%
5 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
101
Fifth Third Bancorp
FITB
$52.6B
$1.69M 0.21%
41,092
+11,503
+39% +$432K
USIG icon
102
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$1.69M 0.21%
+32,765
New +$1.66M
QCOM icon
103
Qualcomm
QCOM
$171B
$1.65M 0.21%
10,373
-509
-5% -$74.9K
KEY icon
104
KeyCorp
KEY
$24.5B
$1.65M 0.21%
94,778
-5,277
-5% -$81.8K
JHG
105
DELISTED
Janus Henderson
JHG
$1.64M 0.2%
42,199
-1,516
-3% -$53.4K
PNC icon
106
PNC Financial Services
PNC
$102B
$1.62M 0.2%
8,685
-3,585
-29% -$607K
D icon
107
Dominion Energy
D
$59.8B
$1.61M 0.2%
28,489
+332
+1% +$18.2K
TSN icon
108
Tyson Foods
TSN
$19.6B
$1.58M 0.2%
28,183
+7,450
+36% +$428K
SCCO icon
109
Southern Copper
SCCO
$165B
$1.52M 0.19%
15,757
-937
-6% -$81.5K
BMY icon
110
Bristol-Myers Squibb
BMY
$130B
$1.51M 0.19%
32,536
-1,511
-4% -$74.2K
CMA
111
DELISTED
Comerica
CMA
$1.49M 0.19%
24,975
+7,950
+47% +$444K
KMB icon
112
Kimberly-Clark
KMB
$36.2B
$1.47M 0.18%
11,378
-60
-0.5% -$8.13K
NJR icon
113
New Jersey Resources
NJR
$5.62B
$1.39M 0.17%
31,028
+3,414
+12% +$160K
SRE icon
114
Sempra
SRE
$56.2B
$1.38M 0.17%
18,191
+2,483
+16% +$184K
MC icon
115
Moelis & Co
MC
$4.91B
$1.37M 0.17%
22,045
+1,583
+8% +$88.8K
PFG icon
116
Principal Financial Group
PFG
$24.4B
$1.35M 0.17%
16,948
-1,740
-9% -$134K
LNC icon
117
Lincoln National
LNC
$8.44B
$1.34M 0.17%
38,595
-855
-2% -$28K
CVS icon
118
CVS Health
CVS
$121B
$1.31M 0.16%
+18,935
New +$1.24M
PFE icon
119
Pfizer
PFE
$150B
$1.3M 0.16%
53,622
-4,446
-8% -$104K
LMT icon
120
Lockheed Martin
LMT
$140B
$1.26M 0.16%
2,730
-19
-0.7% -$8.89K
IWV icon
121
iShares Russell 3000 ETF
IWV
$20.4B
$1.24M 0.15%
3,542
+640
+22% +$208K
IP icon
122
International Paper
IP
$21.8B
$1.23M 0.15%
26,276
-435
-2% -$20.6K
IVZ icon
123
Invesco
IVZ
$13.9B
$1.18M 0.15%
75,023
-2,440
-3% -$35K
BBY icon
124
Best Buy
BBY
$17.5B
$1.15M 0.14%
17,193
+4,747
+38% +$322K
FMC icon
125
FMC
FMC
$1.28B
$1.14M 0.14%
27,194
-3,337
-11% -$133K

Similar funds

Greenwood Capital Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Greenwood Capital Associates held 264 positions worth $804M, up 8.4% from $741M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Greenwood Capital Associates's Q2 2025 filing shows 30 new, 63 increased, 144 reduced and 15 closed positions. Its largest new stake was ASML: 6,795 shares worth $5.45M. The largest sale was Merck, an estimated $6.84M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Greenwood Capital Associates's largest Q2 2025 buy was ASML: 6,795 shares worth $5.45M.
  • Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $14.3M increase.
  • Greenwood Capital Associates's biggest Q2 2025 reduction was IBM, cutting an estimated $2.52M.
  • Greenwood Capital Associates fully exited Merck in Q2 2025, selling an estimated $6.84M.
  • Greenwood Capital Associates's ten largest holdings make up 28% of its $804M portfolio in Q2 2025.
  • Greenwood Capital Associates opened 30 new positions and closed 15 in Q2 2025.
  • Greenwood Capital Associates's portfolio value rose 8.4% quarter-over-quarter to $804M.

Based on Greenwood Capital Associates's 13F filing for Q2 2025, filed 21 Jul 2025.